Media.

Categories

Featured

Media Coverage
February 4th, 2019
Read

IPO ETF ‘Catch and Release’ Strategy

Academic Research
December 19th, 2019
Read

Factor Exposures for the IPOX Portfolio

Media Coverage
January 22nd, 2019
Read

Analysts See 16% Upside For The Holdings of FPX

Media Coverage

Investing In Recent IPOs With ETFs

December 5th, 2016
Read
Media Coverage

Access European IPOs With This New ETF

October 8th, 2018
Read

All media

UPDATE: Reduction of the Minimum Price Increment of the E-mini IPOX 100 U.S Index [...]

https://www.cmegroup.com/content/dam/cmegroup/notices/ser/2020/04/ser-8545RR.pdf

Apr 02, 2020
Read

YahooFinance/Zacks: 5 International Equity ETFs That Topped S&P 500 in Q1

https://finance.yahoo.com/news/5-international-equity-etfs-topped-120012425.html Please use above link, ‘5 International Equity ETFs That Topped S&P 500 in Q1’ in YahooFinance/Zacks. 5 International Equity ETFs That Topped [...]

Apr 01, 2020
Read

Bloomberg: In Europe, the Only Listings in Town Are Spinoffs: ECM Watch

(Bloomberg) — With mounting worries over the economic impact of the coronavirus keeping equity markets in flux, spinoffs are now the only floats [...]

Mar 24, 2020
Read

Reduction of the Minimum Price Increment of the E-mini IPOX 100 U.S Index Futures [...]

https://www.cmegroup.com/content/dam/cmegroup/notices/ser/2020/03/SER-8545.pdf

Mar 03, 2020
Read

Bloomberg: Europe’s Tepid Debuts Find Takers in IPO ETFs: ECM Watch

Europes Tepid Debuts Find Take Please click the above link for the IPOX Europe Story, ‘Europe’s Tepid Debuts Find Takers in IPO ETFs,’ [...]

Feb 24, 2020
Read

Kiplinger: The 13 Hottest IPOs to Watch For in 2020

http://www.kiplingers.com/slideshow/investing/T052-S001-the-13-hottest-ipos-to-watch-for-in-2020/index.html Please use above link, ‘The 13 Hottest IPOs to Watch For in 2020′ in Kiplinger. Kiplinger: The 13 Hottest IPOs to Watch [...]

Jan 30, 2020
Read

Discover How IPOX Can Benefit You

Services
close

  • To access Supplemental Data, please complete your details and continue.

  • In an effort to protect IPOX Schuster and the valuable intellectual property we provide on this website, please acknowledge and accept the following terms and conditions prior to accessing the IPOX Indexes information and their respective data. The identifying information requested is not used for marketing purposes.
  • By clicking the acknowledgement box, you agree to be legally bound by terms set forth herein and you represent that you are accessing the content for you own personal, non-commercial investment purposes or that you are an agent of someone doing the same. The content accessed through this portal is not for professional or commercial use, including any investment management or institutional trading purposes and may not, in any manner, be copied, reproduced, modified, stored and/or used to create any derivative works. Notwithstanding anything to the contrary, all data and information is provided by IPOX Schuster LLC (IPOX Schuster) “as is”. Neither IPOX Schuster nor any of its affiliates or third party licensors guarantee the accuracy, completeness, timeliness or availability of any content nor are any such parties liable for any damages (direct, indirect, incidental, compensatory, punitive or consequential including, without limitation, lost income or lost profits) in connection with any use of such content. You hereby acknowledge that the content is general in nature and is not tailored to the needs of any person, entity or group of persons and IPOX Schuster does not address the suitability of any security. IPOX Schuster does not act as a fiduciary or an investment advisor. IPOX Schuster does not sponsor, endorse, sell, promote or manage any investment product of fund or other vehicle that is offered by third parties and that seeks to provide an investment return based on the returns of any IPOX Index. Display of any particular index on this site does not imply that IPOX Schuster claims any investment product using the index complies with any particular regulation, including but not limited to, ESMA Guidelines on ETFs and other UCITS issues.